BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 24691902)

  • 1. Cognitive and autonomic dysfunction in presymptomatic and early Huntington's disease.
    Kobal J; Melik Z; Cankar K; Strucl M
    J Neurol; 2014 Jun; 261(6):1119-25. PubMed ID: 24691902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autonomic dysfunction in presymptomatic and early symptomatic Huntington's disease.
    Kobal J; Melik Z; Cankar K; Bajrovic FF; Meglic B; Peterlin B; Zaletel M
    Acta Neurol Scand; 2010 Jun; 121(6):392-9. PubMed ID: 20047567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microcirculation response to local cooling in patients with Huntington's disease.
    Melik Z; Kobal J; Cankar K; Strucl M
    J Neurol; 2012 May; 259(5):921-8. PubMed ID: 22012332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autonomic nervous system function in Huntington's disease.
    Andrich J; Schmitz T; Saft C; Postert T; Kraus P; Epplen JT; Przuntek H; Agelink MW
    J Neurol Neurosurg Psychiatry; 2002 Jun; 72(6):726-31. PubMed ID: 12023413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rating scales for cognition in Huntington's disease: Critique and recommendations.
    Mestre TA; Bachoud-Lévi AC; Marinus J; Stout JC; Paulsen JS; Como P; Duff K; Sampaio C; Goetz CG; Cubo E; Stebbins GT; Martinez-Martin P;
    Mov Disord; 2018 Feb; 33(2):187-195. PubMed ID: 29278291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Addenbrooke's Cognitive Examination-Revised accurately detects cognitive decline in Huntington's disease.
    Begeti F; Tan AY; Cummins GA; Collins LM; Guzman NV; Mason SL; Barker RA
    J Neurol; 2013 Nov; 260(11):2777-85. PubMed ID: 23922130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal assessment of the Unified Huntington's Disease Rating Scale (UHDRS) and UHDRS-For Advanced Patients (UHDRS-FAP) in patients with late stage Huntington's disease.
    Winder JY; Achterberg WP; Gardiner SL; Roos RAC
    Eur J Neurol; 2019 May; 26(5):780-785. PubMed ID: 30576046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bradykinesia in early Huntington's disease.
    Sánchez-Pernaute R; Künig G; del Barrio Alba A; de Yébenes JG; Vontobel P; Leenders KL
    Neurology; 2000 Jan; 54(1):119-25. PubMed ID: 10636136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autonomic symptoms in patients and pre-manifest mutation carriers of Huntington's disease.
    Aziz NA; Anguelova GV; Marinus J; van Dijk JG; Roos RA
    Eur J Neurol; 2010 Aug; 17(8):1068-74. PubMed ID: 20192977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HD-CAB: a cognitive assessment battery for clinical trials in Huntington's disease 1,2,3.
    Stout JC; Queller S; Baker KN; Cowlishaw S; Sampaio C; Fitzer-Attas C; Borowsky B;
    Mov Disord; 2014 Sep; 29(10):1281-8. PubMed ID: 25209258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive and Motor Norms for Huntington's Disease.
    Mills JA; Long JD; Mohan A; Ware JJ; Sampaio C
    Arch Clin Neuropsychol; 2020 Aug; 35(6):671-682. PubMed ID: 32407458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are cognitive changes the first symptoms of Huntington's disease? A study of gene carriers.
    Hahn-Barma V; Deweer B; Dürr A; Dodé C; Feingold J; Pillon B; Agid Y; Brice A; Dubois B
    J Neurol Neurosurg Psychiatry; 1998 Feb; 64(2):172-7. PubMed ID: 9489526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The unified Huntington's Disease Rating Scale for advanced patients: validation and follow-up study.
    Youssov K; Dolbeau G; Maison P; Boissé MF; Cleret de Langavant L; Roos RA; Bachoud-Lévi AC
    Mov Disord; 2013 Dec; 28(14):1995-2001. PubMed ID: 24123464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subtle changes among presymptomatic carriers of the Huntington's disease gene.
    Kirkwood SC; Siemers E; Hodes ME; Conneally PM; Christian JC; Foroud T
    J Neurol Neurosurg Psychiatry; 2000 Dec; 69(6):773-9. PubMed ID: 11080230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the association between apathy and deficits of social cognition and executive functions in Huntington's disease.
    Hendel RK; Hellem MNN; Hjermind LE; Nielsen JE; Vogel A
    J Int Neuropsychol Soc; 2023 May; 29(4):369-376. PubMed ID: 36189712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onset of Huntington's disease: can it be purely cognitive?
    Paulsen JS; Long JD
    Mov Disord; 2014 Sep; 29(11):1342-50. PubMed ID: 25142616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Better global and cognitive functioning in choreatic versus hypokinetic-rigid Huntington's disease.
    Hart EP; Marinus J; Burgunder JM; Bentivoglio AR; Craufurd D; Reilmann R; Saft C; Roos RA;
    Mov Disord; 2013 Jul; 28(8):1142-5. PubMed ID: 23495076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychiatric symptoms do not correlate with cognitive decline, motor symptoms, or CAG repeat length in Huntington's disease.
    Zappacosta B; Monza D; Meoni C; Austoni L; Soliveri P; Gellera C; Alberti R; Mantero M; Penati G; Caraceni T; Girotti F
    Arch Neurol; 1996 Jun; 53(6):493-7. PubMed ID: 8660149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Male sexual function in presymptomatic gene carriers and patients with Huntington's disease.
    Kolenc M; Kobal J; Podnar S
    J Neurol Sci; 2015 Dec; 359(1-2):312-7. PubMed ID: 26671134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Female Sexual Dysfunction in Presymptomatic Mutation Carriers and Patients with Huntington's Disease.
    Kolenc M; Kobal J; Podnar S
    J Huntingtons Dis; 2017; 6(2):105-113. PubMed ID: 28482643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.